ProBac - Use of Procalcitonin Level as Part of a Decision Tree to Discontinue Antibiotics When Started Empirically in the ICU in Hemodynamically Stable Patients With no Site of Infection Identified

NCT00407147 Phase 4 TERMINATED

The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.

Details

Lead sponsor	Brahms AG
Phase	Phase 4
Status	TERMINATED
Enrolment	11
Start date	2008-07
Completion	2009-06

Conditions

• Infection
• Bacterial Infection
• Sepsis

Interventions

• Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor

Primary outcomes

• Days on antibiotics beginning with day 4 until the first day without antibiotics (up to max. 28 days follow up) — 28 days

Countries

United States